Amundi
MRK icon

Amundi’s Merck MRK Stock Holding History

Amundi’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.59B Sell
12,342,274
-1,422,680
-10% -$167M 0.38% 45
2026
Q1 		$1.66B Buy
13,764,954
+379,861
+3% +$43.9M 0.45% 37
2025
Q4 		$1.41B Sell
13,385,093
-1,829,094
-12% -$172M 0.38% 44
2025
Q3 		$1.35B Sell
15,214,187
-1,318,470
-8% -$109M 0.43% 42
2025
Q2 		$1.36B Buy
16,532,657
+3,454,941
+26% +$275M 0.47% 37
2025
Q1 		$1.13B Buy
13,077,716
+3,542,036
+37% +$331M 0.41% 47
2024
Q4 		$952M Sell
9,535,680
-6,533,203
-41% -$674M 0.33% 61
2024
Q3 		$1.74B Buy
16,068,883
+3,120,074
+24% +$371M 0.64% 25
2024
Q2 		$1.63B Buy
12,948,809
+282,542
+2% +$36.4M 0.62% 25
2024
Q1 		$1.59B Buy
12,666,267
+287,832
+2% +$35.5M 0.68% 23
2023
Q4 		$1.46B Sell
12,378,435
-2,170,285
-15% -$225M 0.66% 20
2023
Q3 		$1.51B Buy
14,548,720
+1,749,423
+14% +$189M 0.74% 16
2023
Q2 		$1.46B Buy
12,799,297
+352,092
+3% +$40M 0.74% 17
2023
Q1 		$1.38B Buy
12,447,205
+1,939,627
+18% +$209M 0.75% 21
2022
Q4 		$1.17B Sell
10,507,578
-534,826
-5% -$54.7M 0.64% 24
2022
Q3 		$972M Buy
11,042,404
+3,422,066
+45% +$305M 0.58% 30
2022
Q2 		$710M Sell
7,620,338
-805,884
-10% -$71.4M 0.57% 31
2022
Q1 		$720M Buy
8,426,222
+1,508,300
+22% +$119M 0.49% 36
2021
Q4 		$554M Sell
6,917,922
-1,964,036
-22% -$156M 0.35% 64
2021
Q3 		$667M Sell
8,881,958
-1,211,625
-12% -$92.1M 0.47% 42
2021
Q2 		$785M Buy
+10,093,583
New +$751M 0.55% 33

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Amundi's MRK Position: Q2 2026 in Review

Amundi reduced its Merck (MRK) stake by 10% in Q2 2026, selling an estimated $167M and leaving 12,342,274 shares worth $1.59B. The position accounts for 0.38% of the portfolio, ranked #45.

Amundi first reported a position in MRK in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.74B in Q3 2024. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Amundi held 12,342,274 shares of Merck worth $1.59B as of Q2 2026.
  • Amundi sold 1,422,680 Merck shares in Q2 2026, an estimated $167M.
  • Merck made up 0.38% of Amundi's portfolio in Q2 2026, its #45 holding.
  • Amundi first reported a position in Merck in Q2 2021 and has held it in 21 quarters since.
  • Amundi's Merck position peaked at $1.74B in Q3 2024.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.